Genomic cancer medicine explained
Genomic medicine uses genome sequencing to help diagnose illness and provide better, more personalised treatment.
Genomic information can predict how a person’s cancer will respond to surgery or drug therapy, guiding the use of existing treatments, or suggesting more targeted treatments. This can spare some patients costly and complex procedures and can result in better outcomes.
Genomic information also help us understand the genetic drivers that give a person an increased risk of developing cancer, leading to personalised monitoring and more effective early detection.
The Genomic Cancer Medicine Program was established as part of a $24 million, four-year investment by the NSW State Government in using genetic technologies to improve patient outcomes.